Kenneth W. Kousky is Director at Gemphire Therapeutics Inc. (GEMP). They have made 1 open-market trade across 1 company since 2016, most recently 2019-07-24.
CIK 0001638287
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $10K since 2016, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| GEMP | 26,935 | $202K |
Shares reported on the most recent Form 4, priced at the 2019-07-26 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| GEMP | BUY | 2016-08-10 | 2016-08-12 | $10.00 | $10K | +4.7% | +26.3% | -3.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.